BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8761585)

  • 1. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
    Pépin J; Khonde N
    Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
    Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
    Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness.
    Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P
    Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human African trypanosomiasis and normality of the cerebrospinal fluid].
    Pepin J; Milord F; Guern C
    Med Trop (Mars); 1989; 49(1):29-31. PubMed ID: 2725242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.
    Pépin J; Milord F; Khonde A; Niyonsenga T; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1994; 88(4):447-52. PubMed ID: 7570842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 8. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
    Lejon V; Legros D; Savignoni A; Etchegorry MG; Mbulamberi D; Büscher P
    J Neuroimmunol; 2003 Nov; 144(1-2):132-8. PubMed ID: 14597107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current therapy of trypanosomiasis].
    Doua F; Boa Yapo F
    Bull Soc Pathol Exot; 1994; 87(5):337-40. PubMed ID: 7496197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 17. A returning traveller with fever, facial swelling, and skin lesions.
    Richter J; Göbels S; Göbel T; Westenfeld R; Müller-Stöver I; Häussinger D
    BMJ; 2012 Mar; 344():e2092. PubMed ID: 22442353
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.